1.A case of discoid lupus erythematosus in a 42-year-old Filipino female
Alreen C. Miranda ; Maria Jasmin J. Jamora
Journal of the Philippine Dermatological Society 2024;33(Suppl 1):3-3
Discoid Lupus Erythematosus (DLE) is the most common form of chronic cutaneous Lupus Erythematosus (LE). Characteristic lesions cause disfigurement impacting quality of life, with 5% of progress into systemic LE (SLE). Prompt diagnosis avoids sequelae such as scarring, recurrence, and malignancy. Local therapy includes sun protection, steroids, and calcineurin inhibitors (CNIs). Antimalarials and surgical or cosmetic interventions are other options.
Human ; Female ; Adult: 25-44 Yrs Old ; Lupus Erythematosus, Cutaneous ; Lupus Erythematosus, Discoid
2.Upper lip squamous cell carcinoma arising from discoid lupus erythematosus treated with standard wide excision
Janelle G Go ; Melanie Joy Doria-Ruiz ; Daisy King-Ismael
Journal of the Philippine Dermatological Society 2020;29(2):73-77
Introduction: Squamous cell carcinoma (SCC) is a rare complication of long-standing discoid lupus erythematosus
(DLE). The reported risk factors associated with the malignant transformation include chronic inflammation, scarring, immunosuppression, and the dysfunctional healing already evident in discoid lesions. If underdiagnosed and left untreated, this may lead to higher rates of recurrences, metastases and death.
Objective: The main objective of this article is to report the diagnosis and management of a DLE-associated SCC on the upper lip of an elderly Filipino female. A short discussion on the pathogenesis and treatment of this disease entity is also presented.ugs/topical medications, family history and accompanying systemic symptoms were reviewed and analyzed.
Case: A 78-year-old female, pawid maker, developed a rapidly growing verrucous tumor measuring 4.0 x 2.0 x 2.0 cm from a depigmented atrophic plaque located on the upper lip. Initial histopathologic findings were consistent with SCC and DLE. Considering the tumor size and the challenging anatomical location, the surgical oncology and plastic surgery team carried out a wide excision with 5 mm margin of the entire upper lip mass and surrounding plaque, followed by lip reconstruction. Biopsy findings of the excised mass were consistent with the initial findings. Three months post-operation, there was significant wound healing with no recurrences.
Conclusion: Although the incidence is rare, SCC occurring in DLE is considered to be high-risk and should warrant
early recognition and prompt treatment. In this paper, the authors also highlight the use of a standard wide excision in lieu of Mohs Microscopic Surgery as an alternative option where resources are limited.
surgical flaps
;
Lupus Erythematosus, Discoid
;
Carcinoma, Squamous Cell
3.Three Fibrotic Conditions Treated with 5% Topical Imiquimod Cream as an Antifibrotic Agent
Yeo Rye CHO ; Ho Jin KIM ; Jeong Wan SEO ; Tae Hoon KIM ; Ki Ho KIM
Korean Journal of Dermatology 2019;57(5):265-269
Imiquimod, a toll-like receptor agonist, is a topical immunomodulator that induces the production of several cytokines including interferon-alpha, which shows antifibrotic properties. We hypothesized that the antifibrotic effect of imiquimod would soften fibrotic skin lesions. Therefore, we applied topical imiquimod with topical tacrolimus or systemic acitretin in patients with refractory lesions of myxedema, angiolymphoid hyperplasia, and generalized discoid lupus erythematosus and confirmed improvement in fibrotic lesions in these patients. Thus, we conclude that use of imiquimod improves fibrotic skin lesions. This report describes our experience with the treatment of this condition along with a review of the related literature.
Acitretin
;
Angiolymphoid Hyperplasia with Eosinophilia
;
Cytokines
;
Fibrosis
;
Humans
;
Hyperplasia
;
Interferon-alpha
;
Lupus Erythematosus, Discoid
;
Myxedema
;
Skin
;
Tacrolimus
;
Toll-Like Receptors
4.Vitiligo in a Patient with Systemic Lupus Erythematosus: A Case Report.
Hyoung Il KWON ; Eui Hyun OH ; Yun Do JUNG ; Joo Yeon KO
Korean Journal of Dermatology 2018;56(10):620-623
Vitiligo is a multifactorial disorder. Neural, biochemical, and autoimmune mechanisms have been hypothetically suggested as etiopathological contributors to this condition. Autoimmunity focuses primarily on genetic factors and the association between vitiligo and other autoimmune disorders including autoimmune thyroid disease, rheumatoid arthritis, psoriasis, type 1 diabetes, pernicious anemia, and Addison's disease. We describe a 35-year-old man with systemic lupus erythematosus who developed concurrent vitiligo and discoid lupus erythematosus suggesting the possible autoimmune association between these 2 different diseases.
Addison Disease
;
Adult
;
Anemia, Pernicious
;
Arthritis, Rheumatoid
;
Autoimmunity
;
Humans
;
Lupus Erythematosus, Discoid
;
Lupus Erythematosus, Systemic*
;
Psoriasis
;
Thyroid Diseases
;
Vitiligo*
5.Intense Pulsed Light and Q-Switched 1,064-nm Neodymium-Doped Yttrium Aluminum Garnet Laser Treatment for the Scarring Lesion of Discoid Lupus Erythematosus.
Yun Sun BYUN ; Jee Hee SON ; Yong Se CHO ; Bo Young CHUNG ; Hee Jin CHO ; Chun Wook PARK ; Hye One KIM
Annals of Dermatology 2017;29(3):331-333
Discoid lupus erythematosus (DLE) is a chronic form of cutaneous lupus that can cause permanent scarring. Treatment of DLE includes protection from sunlight and artificial sources of ultraviolet light, as well as systemic and topical medications. The first-line standard therapies are antimalarials and topical steroids. Other systemic therapies include systemic steroid, azathioprine, dapsone, and immunosuppressive agents. Topical tacrolimus and pimecrolimus have also been evaluated. Recent studies reported that several treatments, including pulsed dye laser, CO₂ laser, intense pulsed light (IPL), and 1,064-nm long-pulse neodymium-doped yttrium aluminum (Nd:YAG) have been used for the cosmetic treatment of DLE. Here, we report a case of a DLE scar that was successfully treated with a combination therapy of IPL and Q-switched 1,064-nm Nd:YAG laser.
Aluminum*
;
Antimalarials
;
Azathioprine
;
Cicatrix*
;
Dapsone
;
Immunosuppressive Agents
;
Intense Pulsed Light Therapy
;
Lasers, Dye
;
Lupus Erythematosus, Discoid*
;
Steroids
;
Sunlight
;
Tacrolimus
;
Ultraviolet Rays
;
Yttrium*
6.Incidental Focal Acantholytic Dyskeratosis in a Patient with Discoid Lupus Erythematosus: A Possible Role for SPCA1 in the Pathogenesis of the Disease.
Hyeong Rae KIM ; Seul Ki LIM ; Hae Eul LEE ; Myung IM ; Young LEE ; Young Joon SEO ; Jeung Hoon LEE
Annals of Dermatology 2017;29(5):655-657
No abstract available.
Humans
;
Lupus Erythematosus, Discoid*
8.Rituximab for refractory anemia and thrombocytopenia in a patient with systemic lupus erythematosus.
Recto Rhona L. ; Masbang Armin ; Cruz-Bermudez Charito C.
Philippine Journal of Internal Medicine 2016;54(4):1-2
INTRODUCTION: Hematologic manifestations of Systemic Lupus Erythematosus (SLE) such as hemolytic anemia, leucopenia and thrombocytopenia are among the common causes of morbidity and hospitalization among patients. This is a case report of a patient presenting with refractory cytopenias.
CASE: The patient is a 42-year-old female, diagnosed with SLE, having met the Systemic Lupus Erythematosus International Collaboration Clinics Criteria for diagnosis Persistent serositis (pleural effusion and ascites) and worsening of anemia prompted treatment with oral corticosteroid (prednisone 1.0 mg per kg per day) which showed improvement of shortness of breath and pleural effusion. Cytopenias persisted despite increasing IV pulse steroid to 6.0 mkd prednisone then further to 13 mkd prednisone.Rituximab given as 1.0 g infusion once every two weeks for two doses which resulted to improvement of anemia, thrombocytopenia and serositis.
CONCLUSION: Hematologic manifestations may present as life threatening complications of lupus.Most cases are responsive to corticosteroid therapy,however,in a few refractory cases,less used conventional treatment such as rituximab,may provide significant response.
Human ; Female ; Adult ; Serositis ; Prednisone ; Rituximab ; Leukopenia ; Lupus Erythematosus, Systemic ; Thrombocytopenia ; Lupus Erythematosus, Discoid ; Anemia, Hemolytic ; Pleural Effusion ; Adrenal Cortex Hormones ; Dyspnea
9.Dermoscopic Approach to a Small Round to Oval Hairless Patch on the Scalp.
Woo Haing SHIM ; Seung Wook JWA ; Margie SONG ; Hoon Soo KIM ; Hyun Chang KO ; Byung Soo KIM ; Moon Bum KIM
Annals of Dermatology 2014;26(2):214-220
BACKGROUND: Various kinds of alopecia can show small round or oval hairless patch. Dermoscopy could be a simple, useful tool for making a correct diagnosis. OBJECTIVE: The aim of this study is to investigate clinical usefulness of dermoscopy for diseases with small round or oval hairless patch on the scalp. METHODS: Dermoscopic examination was performed for 148 patients with small round or oval hairless patch using DermLite(R) II pro. The type and its patient number of alopecia investigated in the study were as below: alopecia areata (n=81), trichotillomania (n=24), tinea captis (n=13), traction alopecia (n=12), lichen planopilaris (n=8), discoid lupus erythematosus (n=7), congenital triangular alopecia (n=2) and pseudopelade of Brocq (n=1). The significance of dermoscopic findings for each disease were evaluated. RESULTS: Characteristic dermoscopic findings of alopecia areata were tapering hairs and yellow dots. Those of trichotillomania and traction alopecia were broken hairs. Dermoscopic findings of tinea capitis included bent hairs, perifollicular white macules and greasy scales. Discoid lupus erythematosus and lichen planopilaris were characterized by dermoscopic findings of lack of follicular ostia. Furthermore, keratin plugs were frequently seen in discoid lupus erythematosus whereas perifollicular hyperkeratosis and erythema were frequently seen in lichen planopilaris. CONCLUSION: Dermoscopic examination for small round or oval hairless patch showed characteristic findings for each disease. Based on these results, we propose dermoscopic algorithm for small round or oval hairless patch on the scalp.
Alopecia
;
Alopecia Areata
;
Dermoscopy
;
Diagnosis
;
Erythema
;
Hair
;
Humans
;
Lichens
;
Lupus Erythematosus, Discoid
;
Scalp*
;
Tinea
;
Tinea Capitis
;
Traction
;
Trichotillomania
;
Weights and Measures
10.Drug-induced hypersensitivity syndrome in an ANA-negative, anti-dsDNA-negative systemic lupus erythematosus patient.
Garcia Ann Meredith U ; Racaza Geraldine Z ; Macasaet Paolo S ; Mejia Agnes D
Acta Medica Philippina 2014;48(1):78-82
A 50-year-old female presented with rash and multi-organ toxicity after intake of several antibiotics. This unmasked an elderly-onset, non-drug-induced seronegative systemic lupus erythematosus (SLE)which was confirmed by lupus band test (LBT)and skin biopsy staining. This patient presented with the rare combination of drug-induced hypersensitivity syndrome (DIHS)and SLE.
Human ; Female ; Middle Aged ; Humans ; Aged ; Female ; Anti-bacterial Agents ; Lupus Erythematosus, Discoid ; Lupus Erythematosus, Systemic ; Drug Hypersensitivity Syndrome ; Skin ; Exanthema ; Biopsy ; Staining And Labeling


Result Analysis
Print
Save
E-mail